摘要
肺栓塞临床表现多样且无特异性,轻者可无症状,重者可出现休克甚至死亡,预后差异较大。该文简述了基础情况与伴随疾病、影像学异常表现、实验室检查及生化标志物、多指标联合检测对肺栓塞预后的评估价值,提示寻找肺栓塞预后相关的有效生物标志物是指导肺栓塞患者个体化治疗、提高肺栓塞患者生存率的关键。
The clinical manifestations of pulmonary embolism show diversity with no specificity,varying from asymptomatic in less severe cases to shock and even death in severe cases,and the prognosis of pulmonary embolism shows great differences. The study briefly describes the impacts of the basic situation and the accompanying disease,abnormal manifestations of imaging,laboratory biochemical indexes and biomarkers,and multi- index union on the prognosis of pulmonary embolism. The analysis shows that finding effective biomarkers related with the prognosis of pulmonary embolism is the key to guide the individualized treatment and to improve the survival rate of patients with pulmonary embolism.
出处
《中国全科医学》
CAS
CSCD
北大核心
2016年第20期2375-2379,共5页
Chinese General Practice
基金
华北理工大学培育基金项目(SP201505)
关键词
肺栓塞
预后
综述
Pulmonary embolism
Prognosis
Review